Morgan Stanley upgrades Melexis stock rating on automotive recovery

Morgan Stanley upgraded Melexis (EBR:MLXS) from Equalweight to Overweight, raising its price target to EUR80.00 from EUR60.00. The upgrade is predicated on an expected cyclical recovery in automotive semiconductors, growing design win momentum in China, and the company's attractive valuation despite recent share price gains. Morgan Stanley designates Melexis as its most preferred European small-cap semiconductor company, citing long-term structural support from increasing semiconductor content in modernizing automotive platforms and the expanding robotics sector.

Analysis

Morgan Stanley has upgraded Melexis NV (EBR:MLXS) to Overweight from Equalweight, materially increasing its price target to EUR80.00 from EUR60.00. The revision is predicated on several key factors, including an anticipated cyclical recovery in the automotive semiconductor market and specific company momentum evidenced by growing design wins in China. The bank's conviction is further supported by a valuation it deems attractive, despite recent share price gains, and long-term structural tailwinds from increasing semiconductor content in automotive platforms and the expanding robotics sector. This positive outlook is quantitatively backed by a raised fiscal year 2026 earnings per share estimate, now at EUR3.95 from EUR3.69, with the new price target applying a forward multiple of approximately 20x. The strength of this conviction is underscored by Morgan Stanley designating Melexis as its most preferred European small-cap semiconductor company.

Key Decisions for Investors

• Given the strong upgrade, raised earnings estimates, and multiple growth drivers, investors may consider this an opportune moment to build or add to a long position in Melexis.
• The provided valuation metric of 20 times FY2026 estimated earnings for a price target of EUR80.00 offers a clear benchmark for assessing the stock's potential upside and tracking its performance relative to analyst expectations.
• The investment thesis is heavily tied to an automotive semiconductor recovery and success in China; therefore, investors should monitor auto production figures and news on design win pipelines as key validation points for the bull case.